Mergen.financeBiogen
| Year |
|---|
| Jan |
|---|
| Feb |
|---|
| Mar |
|---|
| Apr |
|---|
| May |
|---|
| Jun |
|---|
| Jul |
|---|
| Aug |
|---|
| Sept |
|---|
| Oct |
|---|
| Nov |
|---|
| Dec |
|---|
| Year |
|---|
| 2026 | ▲ 2.2% | ▲ 6.6% | ▼ 4.4% | ▲ 3.2% | ▲ 3.6% | ▲ 10.2% | ▼ 6.1% | ▲ 6.8% | ▲ 4.3% | ▲ 12.3% | ▼ 1.8% | ▲ 41.5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | ▼ 3.3% |
From our own closes, each month-end against the previous month-end. Colour saturates at ▲ 10.2%; an empty cell means no data, a dash means we declined to derive one.
Fiscal period: FY · 2025-12-31 (10-K) — annual data, not TTM · USD · Source: SEC EDGAR (public domain)
Balance-sheet lines and ratios (assets, equity, ROE, ROA, net margin, debt/equity) open on the paid plans. See the plans